| 1 | 12091352 | Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. | Blood | 2002 Jul 15 |
2 |
| 2 | 12855656 | Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. | Clin Cancer Res | 2003 Jul |
3 |
| 3 | 14654558 | Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. | Clin Cancer Res | 2003 Nov 15 |
6 |
| 4 | 19470739 | Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. | Clin Cancer Res | 2009 Jun 1 |
3 |
| 5 | 24885200 | Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor. | BMC Vet Res | 2014 May 6 |
2 |
| 6 | 28884928 | Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma. | Vet Comp Oncol | 2018 Mar |
3 |
| 7 | 29440590 | PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines. | Vet Rec | 2018 Aug 18 |
3 |
| 8 | 30353992 | Plasma cytokeratin-18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib. | J Vet Intern Med | 2018 Nov |
3 |
| 9 | 31365175 | Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine. | Vet Comp Oncol | 2020 Jun |
1 |
| 10 | 31816142 | In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models. | Vet Comp Oncol | 2020 Mar |
2 |
| 11 | 33324695 | Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway. | Front Vet Sci | 2020 |
5 |
| 12 | 34600548 | Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines. | BMC Vet Res | 2021 Oct 2 |
5 |